# Goldenwell Biotech, Inc. (GWLL)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/GWLL/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ -1.9K | $ -54.5K | $ 27.1K | $ 327.2K | $ -343.7K |
| 2025 | $ 64.1K | $ -253.2K | $ -26.5K | N/A | $ -343.7K |
| 2024 | $ 146 | $ -138.2K | $ -129.4K | $ 95.6K | $ -47.2K |
| 2023 | $ 2.5K | $ -126.4K | $ -124.0K | N/A | $ 84.7K |
| 2022 | $ 48.8K | $ -1.03M | $ -1.01M | $ 25.4K | $ 201.6K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.95 |
| Liabilities / Eq | -1.24 |
| Current Ratio | 0.29 |

## Other views

- [Metrics](https://sponda.capital/en/GWLL.md)
- [Charts](https://sponda.capital/en/GWLL/charts.md)
- [Compare](https://sponda.capital/en/GWLL/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.